tiprankstipranks
Trending News
More News >
Kiniksa Pharmaceuticals Ltd. Class A (KNSA)
NASDAQ:KNSA
US Market

Compare Kiniksa Pharmaceuticals (KNSA) vs. Competitors

Compare
546 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Kiniksa Pharmaceuticals
$41.73
$3.16B
93.06
105.57%
6 Buy
0 Hold
0 Sell
Strong Buy
Beam Therapeutics
$28.00
$2.84B
-6.31
4.48%
10 Buy
3 Hold
0 Sell
Strong Buy
Disc Medicine
$79.29
$2.99B
-14.80
26.78%
13 Buy
0 Hold
0 Sell
Strong Buy
Harmony Biosciences Holdings
$37.87
$2.18B
11.93
9.67%
5 Buy
0 Hold
1 Sell
Moderate Buy
Centessa Pharmaceuticals
$22.05
$2.96B
-12.11
36.96%
13 Buy
0 Hold
0 Sell
Strong Buy
CG Oncology, Inc.
$41.93
$3.38B
-21.13
37.66%
12 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
KNSA
Kiniksa Pharmaceuticals
41.73
23.56
129.66%
BEAM
Beam Therapeutics
28.00
2.46
9.63%
IRON
Disc Medicine
79.29
20.55
34.98%
HRMY
Harmony Biosciences Holdings
37.87
1.42
3.90%
CNTA
Centessa Pharmaceuticals
22.05
6.79
44.50%
CGON
CG Oncology, Inc.
41.93
13.25
46.20%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts